Skip to content

Dietary intervention in early stage of primary glomerular diseases with dominant proteinuria:a randomised prospective study

Dietary intervention in early stage of primary glomerular diseases with dominant proteinuria:a randomised prospective study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000614
Enrollment
Unknown
Registered
2009-12-07
Start date
2009-11-18
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary glomerular diseases

Interventions

Group A:Dietary protein intake 0.7g/kg/day
Group B:Dietary protein intake 0.7g/kg/day+ketoacids 0.09g
Group C:Dietary protein intake 1.0g/kg/day

Sponsors

the First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male and female aged 18 to 80 years old; 2. Able and willing to provide signed informed consent; 3. Patients currently treated with oral corticosteroids and immunosuppressant; 4. Stage 1 to 2 CKD patients due to primary glomerular diseases; 5. Estimated Glomerular Filtration Rate >=60ml/min/1.73m2; 6. Urinary protein excretion>=2g/24h; 7. ACEIs and/or ARBs were given to all the patients during the study.

Exclusion criteria

Exclusion criteria: 1. Pateints who are sensitive to corticosteroids treatments: urinary protein excretion negative after corticosteroids treatments within 4 weeks; 2. Pateints with secondary glomerular diseases; 3. Pateints with acute or chronic infections; 4. Emergent stress state,myocardial infarction, cerebrovascular accident, etc; 5. BMI>=28 kg/m2 or BMI<=14 kg/m2. 6. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
serum creatinine, urea nitrogen, 24-hour urinary protein excretion, 24-hour urinary urea nitrogen, LDL-c, HDL-C, VLDL-c;

Secondary

MeasureTime frame
CD3+ cell, NK cell, Th cell, Ts cell, Th/Ts,Hb;

Countries

China

Contacts

Public ContactHongli Lin
linhongli@vip.163.com+86 411 83635963-3368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026